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ABSTRACT
Objective: To report revision external
dacryocystorhinostomy (rE-DCR) results
following failed dacryocystorhinostomy (DCR)
surgery.
Methods: A retrospective review of patients
who underwent rE-DCR between June 2006
and June 2015 at Yıldırım Beyazıt University
Ankara Ataturk Training and Research Hospital
Department of Ophthalmology. Data were
collected on the primary surgery technique
and patient demographics.
Results: Forty-one rE-DCRs were performed on
40 patients after various failed DCR techniques.
Two patients had failed DCR twice, and 38
patients had failed DCR once. Six of these
previous failed DCRs were multidiode laser
DCR, two of them were endoscopic DCR, and
33 were external dacryocystorhinostomy
(E-DCR). In all rE-DCR procedures, silicone
tube intubation was performed, and the tube
was removed at least 6 months after surgery. We
used mitomycin C on 16 patients (40%). At the
last examination, six patients still had epiphora
(15%), and their nasolacrimal passage was
obstructed. Thirty-four patients had no
complaints, and their passages were open
(85%).
Conclusion: The rE-DCR procedure has high
success rates for failed DCR surgeries, whichever
procedure was performed.
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INTRODUCTION
E-DCR is a widely acceptable and common
surgical procedure for primary acquired
nasolacrimal duct obstruction in which a
communication between the lacrimal sac
mucosa and nasal mucosa is created [1].
Because E-DCR has disadvantages such as
leaving incision scars, more noninvasive
surgical procedures have been developed.
Despite the advantages of multidiode laser
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DCR or endoscopic DCR, such as no incision
scarring or less hemorrhaging during the
procedure, E-DCR failures are less frequent
than those of these techniques [2, 3]. Some
studies in the literature report failed E-DCR rates
of 5–10% [4–6] to 35–40% [7–9]. E-DCR is
usually preferred for the treatment of failed
DCRs. In this study we aimed to report our
rE-DCR results after various failed DCR
surgeries.
METHODS
From June 2006 to June 2015 at Yıldırım Beyazıt
University Ankara Ataturk Training and Research
Hospital Department of Ophthalmology, a total
of 41 eyes of 40 patients who underwent rE-DCR
procedures performed after failed DCRs were
gathered from the department files,
retrospectively. All patients were operated on
by the same surgeon under general anesthesia.
All patients were suffering from epiphora. There
was no trauma history in any of the patients
before the epiphora occurred and no ocular
abnormalities. Preoperatively, after a standard
ocular examination including visual acuity,
biomicroscopic anterior segment and fundus
examination, to confirm nasolacrimal duct
obstruction, nasolacrimal duct irrigation was
done, and blocked syringing was seen in all 40
patients. All patients consulted an ear, nose and
throat (ENT) specialist to detect any nasal
pathology. Especially if a nasal septum
deviation on the same side as our surgical area
was reported by the ENT specialist, we postponed
our rE-DCR surgery until the patient had
undergone nasal septum surgery because a nasal
septum deviation blocking the inferior nasal
concha and Hasner valve would make our
surgery more difficult.
A J-shaped skin incision was made with a
surgical knife over the sac area. The periosteum
overlying the lacrimal fossa and the area above
were elevated with a periosteum elevator. If the
bone osteotomy size was insufficient, smaller
than 10 9 10 mm, it was expanded with a
Kerrison punch. The lacrimal sac was opened
in a longitudinal fashion to form anterior and
posterior lacrimal flaps unless it had not been
opened before. If the failed DCR surgery was an
E-DCR, it was obviously harder to recreate flaps
than for the other failed DCR techniques
because of the existence of granulation and
fibrotic tissue. Lacrimal sac mucosa and nasal
mucosa were fashioned in an H shape,
respectively. After controlling hemorrhaging,
anterior and posterior mucosal flaps were
sutured using 6.0 vicryl, and all patients were
silicone intubated. The subcutaneous tissue and
skin were then sutured using 6.0 vicryl in a
continuous fashion. Mitomycin C was used
particularly in patients who had excessive
granulation tissue at the surgical area,
especially surrounding the sac and previous
flaps; 0.02% mg/ml mitomycin C was used
between the flaps with a surgical sponge
saturated with the drug for approximately
2 min and then irrigated. A nasal pack with
antibiotic ointment was placed at the end of the
surgery. After 24 h, the nasal pack was removed,
and syringing was done from the lower
punctum to check the patency of the lacrimal
passage. Postoperatively, patients were given
amoxicillin-clavulanate and naproxen sodium
tablets twice a day for 7 days and local
netilmicin-dexamethasone and ketorolac eye
drops for 2 weeks. The skin sutures were
removed after 7 days. The silicone tube was
removed at least after 6 months. The patients
were followed up at the 1st week and 1, 3, 6 and
12 months. The patients who were followed up
less than 3 months were excluded. Successful
rE-DCR was defined as relief of symptoms and
an open passage at nasolacrimal syringing. All
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procedures followed were in accordance with
the ethical standards of the responsible
committee on human experimentation
(institutional and national) and with the
Helsinki Declaration of 1964, as revised in
2013. Informed consent was obtained from all
patients for being included in the study.
Statistical Analysis
We used Windows SPSS version 16.0 and
descriptive statistics to evaluate our surgical
outcomes and to calculate our mean values.
RESULTS
The mean age was 48.95 ± 12.59 years (range
19–69). There were 31 females (77.5%) and 9
males (22.5%). Two of our patients underwent
failed DCR twice, and 38 patients underwent
failed DCR once. Six of these previous failed
DCRs were multidiode laser DCRs (14.6%), 2 were
endoscopic DCRs (4.8%), and 33 were external
DCRs (80.4%). Three of these 41 failed surgeries
had taken place in our clinic before, and all of
these failed DCR surgeries were E-DCRs. The
mean time was 76.4 ± 107.7 months (range
1–420 months) between the previous failed DCR
and our rE-DCR. The mean time for epiphora
compliant recurrence after failed DCR was
2.39 ± 1.40 months (range 1–6 months). After
rE-DCR, the mean follow-up time was
38.9 ± 35.7 months (range 3–67 months). The
mean silicone tube removal time was
6.2 ± 1.06 months (range 6–12 months).
Among 33 failed E-DCR surgeries, we
detected excessive granulation tissue in 85% of
the patients during the surgery. Also among
eight failed multidiode laser and endoscopic
DCR surgeries, we detected inadequate
osteotomy sites (\10 9 10 mm) in 83% of the
patients during surgery.
One of our patients who underwent failed
DCR twice had E-DCR surgery, and the other
patient underwent laser DCR twice and failed
both. At the last examination after revision
surgery, the patient who had two failed E-DCR
surgeries had a blocked nasolacrimal duct
passage. Intraoperatively, there was excessive
granulation tissue. However, the patient who
had two failed multidiode laser DCR surgeries,
who had an inadequate osteotomy site
intraoperatively, now has an opened
nasolacrimal passage and no complaints.
At the last examination, six patients still had
epiphora (15%) and were blocked when using
the syringing nasolacrimal apparatus. Five of
these patients were female and one male. Three
of our patients’ epiphora complaints continued
just after our rE-DCR surgery, and the other
three patients’ complaints recurred 1 month
after the rE-DCR surgery. Five of these patients’
previous surgeries were E-DCRs, and one patient
had endoscopic DCR surgery. We used 0.02%
mitomycin C on four of these six patients
because of excessive granulation tissue at the
operation site. Thirty-four patients had no
complaints, and their passages were open. The
overall success rate was 85% (Table 1).
DISCUSSION
In this series of 41 failed DCRs, reoperation
using the rE-DCR technique had an 85% success








Endoscopic DCR 2 1 (%50)
Laser DCR 6 6 (%100)
External DCR 33 28 (%84)
All DCR techniques 41 35 (%85)
Ophthalmol Ther (2016) 5:75–80 77
rate. Ari et al. evaluated their 14 months of
follow-up results of rE-DCR surgeries and
reported 85% anatomical success and 78%
both anatomical and functional success [10].
Our success rate is compatible with that of
primary operated DCRs [1, 11, 12]. It is well
known that success in DCR surgery is
compromised by anatomical or functional
problems such as a small osteum or blockage
of the osteum or canalicular system because of
fibrosis [12, 13]. Intraoperatively, we observed
that the reason for the failure in the previous
DCR was likely not creating a proper osteum,
especially for laser-assisted and endoscopic
DCRs. In previous failed E-DCRs, we detected
excessive granulation tissue at the operation site
as the main reason for failure.
It has been shown that the success rate can
be increased by using intraoperative mitomycin
C, an antiproliferative agent placed over the
anastomized posterior flaps and osteotomy site
[13]. In our study, we used mitomycin C in
cases with excessive fibrosis and granulation
tissue.
Another important point in revision cases is
usage of silicone stents. Some studies report that
leaving in silicone tubes for a long time may
cause more granulation tissue, but some authors
suggest long-term use particularly in revision
cases [14–16]. Therefore, because of these
studies and our clinical experiences, we left
the silicone tubes in for at least 6 months after
revision surgery in our cases. But it is obvious
that if the patient does not return for his or her
follow-up on time, the time with a silicone stent
is extended unintentionally.
In different study series, the frequency of
recurrent epiphora after DCR surgery is reported
as 5% to 17% [17, 18]. The most important
factors that play a role in the failure of a DCR
surgery are inadequate rhinostomy, excessive
scar tissue proliferation, anatomic anomalies
and concomitant paranasal sinus infections
[19]. There have been many surgical attempts
for failed DCRs. In general, the preferred
revision DCR surgeries after a failed DCR are
endoscopic non-laser, multidiode laser, external
or transcanalicular laser diode DCR.
Many studies have compared whether
revision endoscopic or external DCR gives
better results after failed DCR surgeries [18,
20]. Although recent studies report similar
success rates in revision endoscopic DCR and
rE-DCR, due to less scarring and providing a
chance to interfere with endonasal pathologies,
endoscopic revision surgeries have been praised
[19–21]. It is also known that, as a disadvantage,
the endoscopic DCR procedure requires more
surgeon experience and more surgical tools.
With the rE-DCR procedure we were able to
remove the granulation tissue from the
drainage site and easily expand the former and
inadequate osteotomy. We think that our high
success rates for rE-DCR procedures are
correlated with our mitomycin C usage in the
appropriate patients, leaving the silicone tube
in for a sufficient time and removing the
silicone tube at the appropriate time in all
patients. Although many different DCR surgical
procedures have been described, rE-DCR is
likely the gold standard surgical technique
after failed DCR surgery [1, 22, 23]. The
retrospective nature and small patient number
are the main limitations of this study; the long
follow-up duration is its main strength.
CONCLUSION
Despite the new techniques in primary acquired
nasolacrimal duct obstruction, external DCR is
still a safe and effective surgical procedure.
However, there is always a possibility of failure
in all surgical procedures. For revision surgeries,
usage of silicone tubes and mitomycin C and
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creating a proper osteum are the most
important factors for a successful surgery. As a
result, the rE-DCR procedure, as a highly
appropriate revision surgery for failed DCRs,
has a high success rate, strengthened by the
usage of a silicone tube and mitomycin C and
creation of a proper osteum.
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